MLH1 and neoplasm: UTS can be accomplished by assessing the expression of the mismatch repair (MMR) proteins (MLH1, MSH2, MSH6, PMS2) by immunohistochemistry (IHC) and/or by PCR‐based microsatellite instability (MSI) analysis in tumor tissue.